164 related articles for article (PubMed ID: 9056007)
1. Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase.
Mendel DB; Cihlar T; Moon K; Chen MS
Antimicrob Agents Chemother; 1997 Mar; 41(3):641-6. PubMed ID: 9056007
[TBL] [Abstract][Full Text] [Related]
2. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
[TBL] [Abstract][Full Text] [Related]
3. Enhanced chemical stability of the intracellular prodrug, 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, relative to its parent compound, cidofovir.
Oliyai R; Lee WA; Visor GC; Yuan LC
Int J Pharm; 1999 Mar; 179(2):257-65. PubMed ID: 10053218
[TBL] [Abstract][Full Text] [Related]
4. Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme.
Tehler U; Nelson CH; Peterson LW; Provoda CJ; Hilfinger JM; Lee KD; McKenna CE; Amidon GL
Antiviral Res; 2010 Mar; 85(3):482-9. PubMed ID: 19969024
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.
Cundy KC; Barditch-Crovo P; Petty BG; Ruby A; Redpath M; Jaffe HS; Lietman PS
Antimicrob Agents Chemother; 1999 Feb; 43(2):271-7. PubMed ID: 9925517
[TBL] [Abstract][Full Text] [Related]
6. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
Cihlar T; Chen MS
Mol Pharmacol; 1996 Dec; 50(6):1502-10. PubMed ID: 8967971
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
[TBL] [Abstract][Full Text] [Related]
8. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
[TBL] [Abstract][Full Text] [Related]
10. Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.
Oliyai R; Shaw JP; Sueoka-Lennen CM; Cundy KC; Arimilli MN; Jones RJ; Lee WA
Pharm Res; 1999 Nov; 16(11):1687-93. PubMed ID: 10571273
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
12. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity.
Eriksson U; Peterson LW; Kashemirov BA; Hilfinger JM; Drach JC; Borysko KZ; Breitenbach JM; Kim JS; Mitchell S; Kijek P; McKenna CE
Mol Pharm; 2008; 5(4):598-609. PubMed ID: 18481868
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Eriksson U; Hilfinger JM; Kim JS; Mitchell S; Kijek P; Borysko KZ; Breitenbach JM; Drach JC; Kashemirov BA; McKenna CE
Bioorg Med Chem Lett; 2007 Feb; 17(3):583-6. PubMed ID: 17161946
[TBL] [Abstract][Full Text] [Related]
14. An efficient process for the synthesis of cyclic HPMPC.
Louie MS; Chapman H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1099-102. PubMed ID: 11562964
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
Zakharova VM; Serpi M; Krylov IS; Peterson LW; Breitenbach JM; Borysko KZ; Drach JC; Collins M; Hilfinger JM; Kashemirov BA; McKenna CE
J Med Chem; 2011 Aug; 54(16):5680-93. PubMed ID: 21812420
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
17. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
Neyts J; Snoeck R; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
[TBL] [Abstract][Full Text] [Related]
18. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.
Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265
[TBL] [Abstract][Full Text] [Related]
19. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals.
Bourne N; Bravo FJ; Bernstein DI
Antiviral Res; 2000 Aug; 47(2):103-9. PubMed ID: 10996398
[TBL] [Abstract][Full Text] [Related]
20. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Bray M; Martinez M; Kefauver D; West M; Roy C
Antiviral Res; 2002 Jun; 54(3):129-42. PubMed ID: 12062386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
